Rosa Arcelús

613 total citations
16 papers, 481 citations indexed

About

Rosa Arcelús is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Rheumatology. According to data from OpenAlex, Rosa Arcelús has authored 16 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Rheumatology. Recurrent topics in Rosa Arcelús's work include Folate and B Vitamins Research (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Rosa Arcelús is often cited by papers focused on Folate and B Vitamins Research (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Rosa Arcelús collaborates with scholars based in Spain. Rosa Arcelús's co-authors include Francisco Blanco‐Vaca, Jordi Ordóñez‐Llanos, Antonio Pérez, Francesc González‐Sastre, José Luís Sánchez-Quesada, Sònia Benı́tez, Alberto de Leiva, Ana Chico, Gemma Carreras‐Badosa and Cristina Bancells and has published in prestigious journals such as Diabetologia, Clinical Chemistry and Atherosclerosis.

In The Last Decade

Rosa Arcelús

15 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Arcelús Spain 9 194 165 110 78 78 16 481
Isabella Catalano Italy 10 296 1.5× 114 0.7× 285 2.6× 103 1.3× 53 0.7× 22 964
X. L. Wang Australia 10 194 1.0× 43 0.3× 150 1.4× 36 0.5× 34 0.4× 10 475
Inge A. M. van den Oever Netherlands 6 47 0.2× 137 0.8× 78 0.7× 56 0.7× 73 0.9× 7 479
Yuri Moriyama Japan 13 415 2.1× 230 1.4× 241 2.2× 67 0.9× 15 0.2× 14 771
Serena Masetti Italy 8 69 0.4× 140 0.8× 57 0.5× 30 0.4× 33 0.4× 8 533
Rikuro HAYASHI Japan 7 316 1.6× 53 0.3× 154 1.4× 96 1.2× 51 0.7× 9 710
Daniele Sticchi Italy 9 67 0.3× 63 0.4× 69 0.6× 62 0.8× 36 0.5× 11 345
Gary Peer Israel 7 77 0.4× 119 0.7× 67 0.6× 25 0.3× 38 0.5× 9 630
Stefano Lattanzio Italy 13 160 0.8× 40 0.2× 102 0.9× 54 0.7× 57 0.7× 18 679
Valentina Lotto Italy 8 64 0.3× 176 1.1× 46 0.4× 75 1.0× 16 0.2× 8 544

Countries citing papers authored by Rosa Arcelús

Since Specialization
Citations

This map shows the geographic impact of Rosa Arcelús's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Arcelús with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Arcelús more than expected).

Fields of papers citing papers by Rosa Arcelús

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Arcelús. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Arcelús. The network helps show where Rosa Arcelús may publish in the future.

Co-authorship network of co-authors of Rosa Arcelús

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Arcelús. A scholar is included among the top collaborators of Rosa Arcelús based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Arcelús. Rosa Arcelús is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Benı́tez, Sònia, Antonio Pérez, José Luís Sánchez-Quesada, et al.. (2006). Electronegative low‐density lipoprotein subfraction from type 2 diabetic subjects is proatherogenic and unrelated to glycemic control. Diabetes/Metabolism Research and Reviews. 23(1). 26–34. 22 indexed citations
2.
Sánchez-Quesada, José Luís, Sònia Benı́tez, Antonio Pérez, et al.. (2005). The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity. Diabetologia. 48(10). 2162–2169. 40 indexed citations
3.
Pérez, Antonio, José M. Cubero, Nuria Sucunza, et al.. (2004). Emerging cardiovascular risk factors in subclinical hypothyroidism: Lack of change after restoration of euthyroidism. Metabolism. 53(11). 1512–1515. 43 indexed citations
4.
Benı́tez, Sònia, Mercedes Camacho, Rosa Arcelús, et al.. (2004). Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Atherosclerosis. 177(2). 299–305. 57 indexed citations
5.
Benı́tez, Sònia, Máximo Camacho, Rosa Arcelús, et al.. (2004). Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cellsRelationship with electronegative LDL. Atherosclerosis. 177(2). 299–305. 36 indexed citations
6.
Calpe‐Berdiel, Laura, Joan Carles Escolà‐Gil, Vicent Ribas, Rosa Arcelús, & Francisco Blanco‐Vaca. (2004). Caracterización de un modelo murino en el que la deficiencia parcial de folato no induce hiperhomocisteinemia. Clínica e Investigación en Arteriosclerosis. 16(5). 192–197.
7.
Camacho, Mercedes, et al.. (2004). LDL modificada con fosfolipasa A2. Relación con la LDL electronegativa. Clínica e Investigación en Arteriosclerosis. 16(4). 133–140. 1 indexed citations
8.
Wägner, Ana M., Jordi Ordóñez‐Llanos, Rosa Arcelús, et al.. (2003). Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretion. Metabolism. 52(8). 1038–1042. 4 indexed citations
9.
Benı́tez, Sònia, José Luís Sánchez-Quesada, Rosa Arcelús, et al.. (2002). Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids. Atherosclerosis. 160(1). 223–232. 62 indexed citations
10.
Blanco‐Vaca, Francisco, et al.. (2000). Comparison of the Abbott IMx® and a High-Performance Liquid Chromatography Method for Measuring Total Plasma Homocysteine. Clinical Chemistry and Laboratory Medicine (CCLM). 38(4). 327–329. 21 indexed citations
11.
Joven, Jorge, Rosa Arcelús, Jordi Camps, et al.. (2000). Determinants of plasma homocyst(e)ine in patients with nephrotic syndrome. Journal of Molecular Medicine. 78(3). 147–154. 8 indexed citations
12.
Joven, Jorge, Josep M. Simó, Elisabet Vilella, et al.. (2000). Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction. Clinical Biochemistry. 33(6). 509–512. 8 indexed citations
13.
Chico, Ana, Antonio Pérez, Rosa Arcelús, et al.. (1998). Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?. Diabetologia. 41(6). 684–693. 164 indexed citations
14.
Kulisevsky, Jaime, et al.. (1995). Levodopa Does Not Aggravate Postural Tremor in Parkinsonʼs Disease. Clinical Neuropharmacology. 18(5). 435–442. 9 indexed citations
15.
Martínez-Brú, Cecília, et al.. (1993). Dipyrone interference on several common biochemical tests. Clinical Chemistry. 39(6). 1033–1036. 3 indexed citations
16.
Martínez-Brú, Cecília, et al.. (1993). Dipyrone interference on several common biochemical tests.. PubMed. 39(6). 1033–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026